Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2018

Puca L, Bareja R, Prandi D, Shaw R, Benelli M, Karthaus WR, et al. Patient derived organoids to model rare prostate cancer phenotypes. Nat Commun. 2018;9(1):2404.

McIntire PJ, Snow JT, Robinson BD, Rao RA, Goyal A, Heymann JJ, et al. Improved correlation of urinary cytology specimens using The Paris System in biopsy-proven upper tract urothelial carcinomas. Cancer Cytopathol. 2018;126(7):498-504.

Kleaveland B, Shi CY, Stefano J, Bartel DP. A Network of Noncoding Regulatory RNAs Acts in the Mammalian Brain. Cell. 2018;174(2):350-362.e17.

Hissong E, Jessurun J, Yantiss RK. Findings in exudates can help distinguish benign gastric ulcers from ulcerated adenocarcinomas. Histopathology. 2018;73(2):215-219.

Ruder B, Murtadak V, Stürzl M, Wirtz S, Distler U, Tenzer S, et al. Chronic intestinal inflammation in mice expressing viral Flip in epithelial cells. Mucosal Immunol. 2018;11(6):1621-1629.

Castellino A, Chiappella A, LaPlant BR, Pederson LD, Gaidano G, Macon WR, et al. Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials. Blood Cancer J. 2018;8(11):108.

Jain M, Robinson BD, Wu B, Khani F, Mukherjee S. Exploring Multiphoton Microscopy as a Novel Tool to Differentiate Chromophobe Renal Cell Carcinoma From Oncocytoma in Fixed Tissue Sections. Arch Pathol Lab Med. 2018;142(3):383-390.

Schäffner I, Minakaki G, M Khan A, Balta E-, Schlötzer-Schrehardt U, Schwarz TJ, et al. FoxO Function Is Essential for Maintenance of Autophagic Flux and Neuronal Morphogenesis in Adult Neurogenesis. Neuron. 2018;99(6):1188-1203.e6.

Nakahara T, Petrov A, Tanimoto T, Chaudhry F, Narula N, Seshan SV, et al. Molecular Imaging of Apoptosis in Cancer Therapy-Related Cardiac Dysfunction Before LVEF Reduction. JACC Cardiovasc Imaging. 2018;11(8):1203-1205.

Tabbo F, Nottegar A, Guerrera F, Migliore E, Luchini C, Maletta F, et al. Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma. Hum Pathol. 2018;75:167-178.